![]() | Up a level |
Fontrier, Anna-Maria, Kamphuis, Bregtje W. and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2023)
How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe.
European Journal of Health Economics.
ISSN 1618-7598
Fontrier, Anna-Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2023)
Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the Canadian province of Ontario?
Value in Health, 26 (7).
1011 - 1021.
ISSN 1098-3015
Gill, Jennifer, Chávez, Danitza, Main, Caitlin, Miracolo, Aurelio, Fontrier, Anna-Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2023)
Sustainable healthcare financing for SDG3 in ASEAN-6.
.
Medical Technology Research Group (MTRG), The London School of Economics and Political Science, London, UK.
Fontrier, Anna-Maria (2022) Market access for medicines treating rare diseases: association between specialised processes for orphan medicines and funding recommendations. Social Science & Medicine, 306. ISSN 0277-9536
Fontrier, Anna-Maria, Visintin, Erica and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2022)
Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries.
PHARMACOECONOMICS-OPEN, 6 (3).
315 - 328.
ISSN 2509-4262
Kamphuis, Bregtje, Fontrier, Anna-Maria, Haig, Madeleine, Politopoulou, Konstantina, Salyga, Hana, Gentilini, Arianna and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2021)
Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia.
.
LSE Consulting, London, UK.
Kamphuis, Bregtje, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina, Salyga, Hana and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2021)
Access to medicines in Europe delays and challenges for patient access: delays and challenges for patient access.
.
LSE Consulting, London, UK.
Kanavos, Panos ORCID: 0000-0001-9518-3089, Kamphuis, Bregtje, Fontrier, Anna-Maria, Parkin, Georgia Colville, Saleh, Shadi and Akhras, Kasey S.
(2020)
Pricing of in-patent pharmaceuticals in the Middle East and North Africa: is external reference pricing implemented optimally?
Health Policy, 124 (12).
1297 - 1309.
ISSN 0168-8510
Gill, Jennifer, Fontrier, Anna-Maria, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2020)
Access to personalised oncology in Europe.
.
Gill, Jennifer, Fontrier, Anna-Maria, Kyriopoulos, Dionysis and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2019)
Variations in external reference pricing implementation: does it matter for public policy?
European Journal of Health Economics, 20 (9).
1375 - 1397.
ISSN 1618-7598
Fontrier, Anna-Maria, Gill, Jennifer and Kanavos, Panos ORCID: 0000-0001-9518-3089
(2019)
International impact of external reference pricing: should national policy makers care?
European Journal of Health Economics, 20 (8).
1147 - 1164.
ISSN 1618-7598
Kanavos, Panos ORCID: 0000-0001-9518-3089, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina and Boekstein, Nicola
(2017)
The Impact of External Reference Pricing within and across Countries.
.
London School of Economics and Political Science, London, UK.
Kanavos, Panos ORCID: 0000-0001-9518-3089, Fontrier, Anna-Maria, Gill, Jennifer, Kyriopoulos, Dionysis and Boekstein, Nicola
(2017)
The Implementation of External Reference Pricing within and across Country Borders.
.
London School of Economics and Political Science, London, UK.